Top Markets
#1 Akedo Akedo +57.11%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.98%
#4 Velvet Velvet +42.35%
#5 Black Phoenix Black Phoenix +34.56%
#6 Ο„emplar Ο„emplar +28.04%
#7 Ribbita by Virtuals Ribbita by Virtuals +19.92%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +18.68%
#9 Bitway Bitway +17.09%
#10 Cap Cap +16.13%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
Psyence Group Inc. Psyence Group Inc.

Psyence Group Inc.

PSYG
Rank in Stocks #38237
Psyence Group Inc. is a life sciences biotechnology company primarily engaged... Psyence Group Inc. is a life sciences biotechnology company primarily engaged in the commercial cultivation and production of psilocybin mushrooms. This naturally sourced psilocybin is intended for therapeutic applications, addressing a broad spectrum of mental health conditions and other medical ailments. The company is actively formulating pharmaceutical-grade psilocybin treatments designed to mitigate psychological trauma and recognized disorders such as anxiety, depression, post-traumatic stress disorder (PTSD), and the emotional distress linked to grief and bereavement. Furthermore, Psyence Group develops, distributes, and sells over-the-counter functional mushroom nutraceuticals, entirely free of psilocybin, under its GOODMIND brand. Established in 2019, the company maintains its headquarters in Toronto, Canada.
Share Price
$0.08765138
Last synced: 2025-12-23
Market Cap
$1.11M
Change (1 day)
0.45%
Change (1 year)
-28.78%
Country
CA
Trade Psyence Group Inc. (PSYG)

Category

Healthcare
Number of shares outstanding for Psyence Group Inc. (PSYG)
Number of shares outstanding as of August 2026: 0
According to Psyence Group Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Psyence Group Inc. (PSYG) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 892.40M -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.44B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.77B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 796.00M -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 0.00 -
US